# XPOVIO
> **NDA212306** · New Drug Application · Sponsor: KARYOPHARM THERAPS · Approved 2019-07-03
## Drug
- **FDA Application Number:** NDA212306
- **Application type:** New Drug Application
- **Brand name:** XPOVIO
- **Generic name:** SELINEXOR
- **Active ingredients:** SELINEXOR
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** KARYOPHARM THERAPS
- **Manufacturer:** Karyopharm Therapeutics Inc.
- **First approval:** 2019-07-03
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212306)
---
*MORVS · CC0 1.0*